Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

The search for common pathways underlying asthma and COPD

Authors Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N

Received 26 October 2012

Accepted for publication 8 December 2012

Published 25 January 2013 Volume 2013:8 Pages 65—78

DOI http://dx.doi.org/10.2147/COPD.S39617

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Yoshiko Kaneko, Yohei Yatagai, Hideyasu Yamada, Hiroki Iijima, Hironori Masuko, Tohru Sakamoto, Nobuyuki Hizawa

Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Abstract: Recently, several genes and genetic loci associated with both asthma and chronic obstructive pulmonary disease (COPD) have been described as common susceptibility factors for the two diseases. In complex diseases such as asthma and COPD, a large number of molecular and cellular components may interact through complex networks involving gene–gene and gene–environment interactions. We sought to understand the functional and regulatory pathways that play central roles in the pathobiology of asthma and COPD and to understand the overlap between these pathways. We searched the PubMed database up to September 2012 to identify genes found to be associated with asthma, COPD, tuberculosis, or essential hypertension in at least two independent reports of candidate-gene associations or in genome-wide studies. To learn how the identified genes interact with each other and other cellular proteins, we conducted pathway-based analysis using Ingenuity Pathway Analysis software. We identified 108 genes and 58 genes that were significantly associated with asthma and COPD in at least two independent studies, respectively. These susceptibility genes were grouped into networks based on functional annotation: 12 (for asthma) and eleven (for COPD) networks were identified. Analysis of the networks for overlap between the two diseases revealed that the networks form a single complex network with 229 overlapping molecules. These overlapping molecules are significantly involved in canonical pathways including the “aryl hydrocarbon receptor signaling,” “role of cytokines in mediating communication between immune cells,” “glucocorticoid receptor signaling,” and “IL-12 signaling and production in macrophages” pathways. The Jaccard similarity index for the comparison between asthma and COPD was 0.81 for the network-level comparison, and the odds ratio was 3.62 (P < 0.0001) for the asthma/COPD pair in comparison with the tuberculosis/ essential hypertension pair. In conclusion, although the identification of asthma and COPD networks is still far from complete, these networks may be used as frameworks for integrating other genome-scale information including expression profiling and phenotypic analysis. Network overlap between asthma and COPD may indicate significant overlap between the pathobiology of these two diseases, which are thought to be genetically related.

Keywords: COPD, asthma, network, common pathways, aryl hydrocarbon receptor signaling

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Silver nanoparticles cause complications in pregnant mice

Zhang XF, Park JH, Choi YJ, Kang MH, Gurunathan S, Kim JH

International Journal of Nanomedicine 2015, 10:7057-7071

Published Date: 13 November 2015

Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance

Yu XW, Yang G, Shi YJ, Su C, Liu M, Feng B, Zhao L

International Journal of Nanomedicine 2015, 10:7045-7056

Published Date: 12 November 2015

Connectomics in psychiatric research: advances and applications

Cao M, Wang Z, He Y

Neuropsychiatric Disease and Treatment 2015, 11:2801-2810

Published Date: 29 October 2015

Efficacy of needle-placement technique in radiofrequency ablation for treatment of lumbar facet arthropathy

Loh JT, Nicol AL, Elashoff D, Ferrante FM

Journal of Pain Research 2015, 8:687-694

Published Date: 7 October 2015

Physiologically based pharmacokinetic modeling of zinc oxide nanoparticles and zinc nitrate in mice

Chen WY, Cheng YH, Hsieh NH, Wu BC, Chou WC, Ho CC, Chen JK, Liao CM, Lin P

International Journal of Nanomedicine 2015, 10:6277-6292

Published Date: 5 October 2015

Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks

Shalaby KS, Soliman ME, Casettari L, Bonacucina G, Cespi M, Palmieri GF, Sammour OA, El Shamy AA

International Journal of Nanomedicine 2014, 9:4953-4964

Published Date: 23 October 2014

Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery

Unterweger H, Tietze R, Janko C, Zaloga J, Lyer S, Dürr S, Taccardi N, Goudouri OM, Hoppe A, Eberbeck D, Schubert DW, Boccaccini AR, Alexiou C

International Journal of Nanomedicine 2014, 9:3659-3676

Published Date: 5 August 2014